Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

Evidence: How to evaluate the efficacy of medicines

To determine whether a drug or vaccine works against a given disease, the concept of evidence is used. But what does that mean and how do you evaluate evidence?

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2


Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.


Dexamethasone can be used for the treatment of certain COVID-19 patients

25 September 2020

Dexamethasone can be used for the treatment of hospitalised COVID-19 patients requiring supplemental oxygen. This has been confirmed by the European Medicines Agency (EMA) after a review of the results from the so-called RECOVERY study on the use of dexamethasone in the treatment of COVID-19.

Second contract ensures access to a potential vaccine for COVID-19

25 September 2020

Denmark and EU part of an international vaccine alliance to ensure COVID-19 vaccines for low- and middle-income countries

25 September 2020

Final report on market dialogue regarding the acquisition of a future pharmacovigilance system

24 September 2020